<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115853">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01725568</url>
  </required_header>
  <id_info>
    <org_study_id>60</org_study_id>
    <nct_id>NCT01725568</nct_id>
  </id_info>
  <brief_title>BioMonitor Master Study</brief_title>
  <acronym>BioMonitor</acronym>
  <official_title>Master Study of the Implantable Cardiac Monitor &quot;BioMonitor&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Slovakia: State Institute for Drug Control</authority>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BioMonitor is an implantable cardiac monitor used to automatically detect and record
      episodes of arrhythmia in patients with bradycardia, tachycardia, asystole and atrial
      fibrillation. The study will be conducted to support regulatory approvals outside of Europe.
      This BioMonitor Master study is designed to investigate the clinical efficacy and safety of
      the BioMonitor.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>SADE free-rate</measure>
    <time_frame>at 3 month follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>SADE free-rate &gt; 90% at 3 month follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of appropriate QRS detection</measure>
    <time_frame>at 6 week follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Rate of appropriate QRS detection &gt; 90% (based on comparison with Holter ECG recording)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Sensitivity and Positive Predictive of episode detection</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sensitivity and Positive Predictive Value of each automatically detected cardiac arrhythmia that was stored as subcutaneous electrocardiogram by the BioMonitor (6 week, 3 and 12 month follow-up data)</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">142</enrollment>
  <condition>ATRIAL FIBRILLATION, Syncope</condition>
  <arm_group>
    <arm_group_label>Implantable cardiac monitor diagnostics</arm_group_label>
    <description>Patients has standard indication for implantable cardiac monitor diagnostic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioMonitor</intervention_name>
    <description>Implantable cardiac monitor</description>
    <arm_group_label>Implantable cardiac monitor diagnostics</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with standard ICM indication who are referred to the hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected cardiac arrhythmia OR Previous AF diagnosis OR AF diagnosis before or after
             ablation procedure OR Stroke of unknown origin.

        Exclusion Criteria:

          -  Implanted ICD or cardiac pacemaker

          -  Allergy to patch electrodes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dietmar Baensch, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 11, 2013</lastchanged_date>
  <firstreceived_date>November 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Syncope</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
